Related Experiment Video

Updated: Mar 25, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

2.0K

Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma

Emanuele Cencini1, Alberto Fabbri1, Monica Bocchia1

  • 1Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.

British Journal of Haematology
|February 26, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Hodgkin lymphomachemosensitivitylymphoid malignanciestherapy

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K